Avecho Biotechnology Ltd - Company Profile and SWOT Analysis
Summary
Avecho Biotechnology Ltd - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Avecho Biotechnology Ltd (Avecho) is a research-driven biotechnology firm that develops and commercializes human and animal health products. The company's product portfolio includes daptomycin, propofol injection, oxymorphone patch, diclofenac gel, oxycodone patch, tretinoin gel and transdermal opioid patches. Its products are used in various applications including injectable dosage forms, feed additives, oral dosage forms, and topical and transdermal dosage forms. Avecho also develops cannabinoid products in partnership with major drug manufacturers. The company markets products under Vital ET, Voveran, Instanac, and TPM brand names. The company collaborates with partners like Novartis and Themis Medicare for product commercialization. It has business presence in Australia, India, Switzerland, and the US. Avecho is headquartered in Clayton, Victoria, Australia.
Scope
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook